SURAKSHA DIAGNOSTIC
Back to Cashflow Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-25 Cr | ₹-24 Cr | ₹1.09 Cr | ₹3.21 Cr | ₹-10 Cr |
What is the latest Cash Flow from Financing Activities ratio of SURAKSHA DIAGNOSTIC ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-25 Cr |
Mar2023 | ₹-24 Cr |
Mar2022 | ₹1.09 Cr |
Mar2021 | ₹3.21 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Financing Activities of SURAKSHA DIAGNOSTIC Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-25 Cr | Negative | |
Mar2023 | ₹-24 Cr | Negative | |
Mar2022 | ₹1.09 Cr | -66.15 | |
Mar2021 | ₹3.21 Cr | Positive | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Financing Activities of peers of SURAKSHA DIAGNOSTIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SURAKSHA DIAGNOSTIC | ₹1,690.1 Cr | 1.4% | 0.3% | NA | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹123,001.0 Cr | 1.1% | 3.3% | 40.2% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹105,618.0 Cr | -0.2% | 4.9% | 15.9% | Stock Analytics | |
FORTIS HEALTHCARE | ₹60,102.2 Cr | 3% | 4.5% | 66.5% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹39,862.6 Cr | -1% | 2.5% | 63.1% | Stock Analytics | |
GLOBAL HEALTH | ₹35,969.5 Cr | 2.8% | 12.9% | 9.4% | Stock Analytics |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SURAKSHA DIAGNOSTIC | 1.4% |
0.3% |
|
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses